Genentech Inc. |
Roche |
pharmaceuticals |
2000 |
MULTI-AG |
$19,000,000 |
Warner-Lambert |
Pfizer |
pharmaceuticals |
2004 |
FDA |
$430,000,000 |
Warner-Lambert |
Pfizer |
pharmaceuticals |
2004 |
MULTI-AG |
(*) $190,000,000 |
Serono, S.A. |
Merck KGaA (EMD) |
pharmaceuticals |
2005 |
FDA |
$704,000,000 |
Eli Lilly and Company |
Eli Lilly |
pharmaceuticals |
2005 |
FDA |
$36,000,000 |
Serono Inc. |
Merck KGaA (EMD) |
pharmaceuticals |
2005 |
MULTI-AG |
(*) $262,000,000 |
InterMune Inc. |
Roche |
pharmaceuticals |
2006 |
FDA |
$36,900,000 |
Schering-Plough Corporation |
Merck |
pharmaceuticals |
2006 |
USAO |
$435,000,000 |
InterMune Inc. |
Roche |
pharmaceuticals |
2006 |
MULTI-AG |
(*) $6,700,000 |
Schering-Plough Corporation |
Merck |
pharmaceuticals |
2006 |
MULTI-AG |
(*) $91,602,000 |
Bristol-Myers Squibb Company |
Bristol-Myers Squibb |
pharmaceuticals |
2007 |
DOJ_CIVIL |
$515,000,000 |
Medicis Pharmaceutical Corporation |
Bausch Health |
pharmaceuticals |
2007 |
DOJ_CIVIL |
$9,800,000 |
Cell Therapeutics Inc. |
|
|
2007 |
FDA |
$10,500,000 |
Specialty Distribution Services Inc. |
Cigna |
healthcare services |
2007 |
USAO |
$10,500,000 |
Jazz Pharmaceuticals Inc. |
Jazz Pharmaceuticals |
pharmaceuticals |
2007 |
USAO |
$20,000,000 |
Medicis Pharmaceutical Corporation |
Bausch Health |
pharmaceuticals |
2007 |
MULTI-AG |
(*) $4,000,000 |
Purdue Pharma |
Purdue Pharma |
pharmaceuticals |
2007 |
MULTI-AG |
$19,500,000 |
Cephalon Inc |
Teva Pharmaceutical Industries |
pharmaceuticals |
2008 |
FDA |
$425,000,000 |
Otsuka American Pharmaceutical Inc. |
Otsuka Pharmaceutical |
pharmaceuticals |
2008 |
FDA |
$4,000,000 |
Cephalon Inc. |
Teva Pharmaceutical Industries |
pharmaceuticals |
2008 |
MULTI-AG |
(*) $116,000,000 |
Cephalon, Inc. |
Teva Pharmaceutical Industries |
pharmaceuticals |
2008 |
CT-AG |
$6,150,000 |
Eli Lilly and Company |
Eli Lilly |
pharmaceuticals |
2008 |
MULTI-AG |
$62,000,000 |
Otsuka American Pharmaceutical Inc. |
Otsuka Pharmaceutical |
pharmaceuticals |
2008 |
MULTI-AG |
(*) $1,700,000 |
Pfizer Inc. |
Pfizer |
pharmaceuticals |
2008 |
MULTI-AG |
$60,000,000 |
Spectranetics Corporation |
Royal Philips |
diversified |
2009 |
FDA |
$5,000,000 |
Pfizer Inc. |
Pfizer |
pharmaceuticals |
2009 |
FDA |
$2,300,000,000 |
Endoscopic Technologies Inc. |
|
|
2009 |
DOJ_CIVIL |
$1,400,000 |
Eli Lilly and Company |
Eli Lilly |
pharmaceuticals |
2009 |
FDA |
$1,415,000,000 |
Eli Lilly and Co. |
Eli Lilly |
pharmaceuticals |
2009 |
CT-AG |
$25,100,000 |
Eli Lilly and Co. |
Eli Lilly |
pharmaceuticals |
2009 |
ID-AG |
$13,000,000 |
Eli Lilly and Company |
Eli Lilly |
pharmaceuticals |
2009 |
MULTI-AG |
(*) $361,828,456 |
GlaxoSmithKline |
GlaxoSmithKline |
pharmaceuticals |
2009 |
KY-AG |
$661,860 |
Elan Corporation PLC |
Perrigo |
pharmaceuticals |
2010 |
FDA |
$203,000,000 |
Eisai Inc. |
Eisai |
pharmaceuticals |
2010 |
FDA |
$11,000,000 |
Novartis Pharmaceuticals Corporation |
Novartis |
pharmaceuticals |
2010 |
FDA |
$422,500,000 |
Allergan Inc. |
AbbVie |
pharmaceuticals |
2010 |
FDA |
$600,000,000 |
Ortho-McNeil Pharmaceutical LLC |
Johnson & Johnson |
pharmaceuticals |
2010 |
FDA |
$81,000,000 |
AstraZeneca LP |
AstraZeneca |
pharmaceuticals |
2010 |
FDA |
$520,000,000 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation |
Novartis |
pharmaceuticals |
2010 |
FDA |
$72,500,000 |
Atricure Inc. |
AtriCure |
medical equipment and supplies |
2010 |
FDA |
$3,760,000 |
GeneScience Pharmaceutical Company |
|
|
2010 |
USAO |
$7,500,000 |
Allergan Inc. |
AbbVie |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $14,750,000 |
AstraZeneca Pharmaceuticals LP |
AstraZeneca |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $218,092,993 |
Eisai Inc. |
Eisai |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $4,658,249 |
Elan Corp. |
Perrigo |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $43,399,040 |
Eli Lilly |
Eli Lilly |
pharmaceuticals |
2010 |
AR-AG |
$18,500,000 |
Eli Lilly |
Eli Lilly |
pharmaceuticals |
2010 |
MS-AG |
$18,500,000 |
Eli Lilly |
Eli Lilly |
pharmaceuticals |
2010 |
LA-AG |
$20,000,000 |
GlaxoSmithKline |
GlaxoSmithKline |
pharmaceuticals |
2010 |
KY-AG |
$3,700,000 |
Novartis Pharmaceuticals Corporation |
Novartis |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $88,258,694 |
Novartis Vaccines & Diagnostics Inc. and Novartis Pharmaceuticals Corporation |
Novartis |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $29,000,000 |
Ortho-McNeil Pharmaceutical LLC |
Johnson & Johnson |
pharmaceuticals |
2010 |
MULTI-AG |
(*) $24,681,516 |
Stryker Biotech |
Stryker |
medical equipment and supplies |
2010 |
MA-AG |
$135,000 |
Merck, Sharp & Dohme |
Merck |
pharmaceuticals |
2011 |
FDA |
$950,000,000 |
Pfizer Inc. |
Pfizer |
pharmaceuticals |
2011 |
FDA |
$14,500,000 |
Scios Inc. |
Johnson & Johnson |
pharmaceuticals |
2011 |
FDA |
$85,000,000 |
Novo Nordisk Inc. |
Novo Holdings A/S |
pharmaceuticals |
2011 |
FDA |
$25,000,000 |
UCB Inc. |
UCB |
pharmaceuticals |
2011 |
FDA |
$34,000,000 |
Forest Pharmaceuticals Inc. |
AbbVie |
pharmaceuticals |
2011 |
FDA |
$164,000,000 |
Google Inc. |
Alphabet Inc. |
information technology |
2011 |
FDA |
$500,000,000 |
AstraZeneca Pharmaceuticals |
AstraZeneca |
pharmaceuticals |
2011 |
MULTI-AG |
$68,500,000 |
Novo Nordisk Inc. |
Novo Holdings A/S |
pharmaceuticals |
2011 |
MULTI-AG |
(*) $3,574,209 |
Stryker Biotech, LLC |
Stryker |
medical equipment and supplies |
2011 |
OR-AG |
$167,000 |
UCB Inc. |
UCB |
pharmaceuticals |
2011 |
MULTI-AG |
(*) $9,893,322 |
Globus Medical Inc. |
Globus Medical |
medical equipment and supplies |
2012 |
FDA |
$550,000 |
GlaxoSmithKline LLC |
GlaxoSmithKline |
pharmaceuticals |
2012 |
FDA |
$3,000,000,000 |
Abbott Laboratories Inc. |
AbbVie |
pharmaceuticals |
2012 |
FDA |
$1,500,000,000 |
Cypress Pharmaceutical Inc. |
Currax Pharmaceuticals |
pharmaceuticals |
2012 |
FDA |
$2,800,000 |
Amgen Inc. |
Amgen |
pharmaceuticals |
2012 |
FDA |
$762,000,000 |
Victory Pharma Inc. |
|
|
2012 |
DOJ_CIVIL |
$11,420,743 |
Healthpoint Ltd. and DFB Pharmaceuticals |
|
|
2012 |
FDA |
$28,000,000 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Boehringer Ingelheim |
pharmaceuticals |
2012 |
FDA |
$95,000,000 |
Abbott Laboratories |
AbbVie |
pharmaceuticals |
2012 |
MULTI-AG |
(*) $339,148,643 |
Amgen Inc. |
Amgen |
pharmaceuticals |
2012 |
MULTI-AG |
(*) $612,000,000 |
Boehringer-Ingelheim Pharmaceuticals, Inc. |
Boehringer Ingelheim |
pharmaceuticals |
2012 |
MULTI-AG |
(*) $95,000,000 |
GlaxoSmithKline |
GlaxoSmithKline |
pharmaceuticals |
2012 |
MULTI-AG |
(*) $477,792,391 |
Janssen Pharmaceuticals, Inc. |
Johnson & Johnson |
pharmaceuticals |
2012 |
MULTI-AG |
$181,000,000 |
Johnson & Johnson |
Johnson & Johnson |
pharmaceuticals |
2012 |
TX-AG |
$158,000,000 |
Merck Sharp & Dohme Corp. |
Merck |
pharmaceuticals |
2012 |
MULTI-AG |
(*) $201,975,000 |
Novartis Pharmaceuticals |
Novartis |
pharmaceuticals |
2012 |
TX-AG |
$6,638,250 |
Pfizer Inc. |
Pfizer |
pharmaceuticals |
2012 |
MULTI-AG |
$42,900,000 |
Johnson & Johnson |
Johnson & Johnson |
pharmaceuticals |
2013 |
FDA |
$2,200,000,000 |
Wyeth Pharmaceuticals Inc. |
Pfizer |
pharmaceuticals |
2013 |
FDA |
$490,900,000 |
Par Pharmaceutical Companies Inc. |
Endo International |
pharmaceuticals |
2013 |
FDA |
$45,000,000 |
Janssen Pharmaceuticals, Inc. |
Johnson & Johnson |
pharmaceuticals |
2013 |
USAO |
$410,000,000 |
AstraZeneca |
AstraZeneca |
pharmaceuticals |
2013 |
KY-AG |
$5,500,000 |
Healthpoint Ltd. |
|
|
2013 |
MULTI-AG |
(*) $28,000,000 |
ISTA Pharmaceuticals, Inc. |
Bausch Health |
pharmaceuticals |
2013 |
MULTI-AG |
(*) $390,253 |
Janssen Pharmaceuticals, Inc. |
Johnson & Johnson |
pharmaceuticals |
2013 |
MA-AG |
$15,100,000 |
Johnson & Johnson |
Johnson & Johnson |
pharmaceuticals |
2013 |
MULTI-AG |
(*) $541,000,000 |
Mylan Specialty, L.P. |
Viatris |
pharmaceuticals |
2013 |
MA-AG |
$250,000 |
Par Pharmaceutical Companies Inc. |
Endo International |
pharmaceuticals |
2013 |
MULTI-AG |
(*) $22,500,000 |
Pfizer Inc. |
Pfizer |
pharmaceuticals |
2013 |
MA-AG |
$375,000 |
Wyeth Pharmaceuticals, Inc. |
Pfizer |
pharmaceuticals |
2013 |
MULTI-AG |
(*) $257,400,000 |
Endo Health Solutions Inc. |
Endo International |
pharmaceuticals |
2014 |
FDA |
$192,700,000 |
Shire Pharmaceuticals LLC |
Takeda Pharmaceutical |
pharmaceuticals |
2014 |
FDA |
$56,500,000 |
CareFusion |
Becton Dickinson |
medical equipment and supplies |
2014 |
MULTI-AG |
(*) $40,100,000 |
Endo Health Solution |
Endo International |
pharmaceuticals |
2014 |
MULTI-AG |
(*) $173,000,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. |
Johnson & Johnson |
pharmaceuticals |
2014 |
MT-AG |
$5,900,000 |
Organon |
Merck |
pharmaceuticals |
2014 |
MULTI-AG |
$31,000,000 |
Pfizer |
Pfizer |
pharmaceuticals |
2014 |
MULTI-AG |
$35,000,000 |